Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11678-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11678-1-AP, RRID:AB_2060078
- Product name
- ARPP-19 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ARPP-19 antibody (Cat. #11678-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
Phosphoproteome Profiling Revealed the Importance of mTOR Inhibition on CDK1 Activation to Further Regulate Cell Cycle Progression.
ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer.
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Increased ARPP-19 expression is associated with hepatocellular carcinoma.
Padi SKR, Vos MR, Godek RJ, Fuller JR, Kruse T, Hein JB, Nilsson J, Kelker MS, Page R, Peti W
Nature 2024 Jan;625(7993):195-203
Nature 2024 Jan;625(7993):195-203
Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
Xia X, Zhang H, Xia P, Zhu Y, Liu J, Xu K, Yuan Y
Frontiers in oncology 2021;11:733595
Frontiers in oncology 2021;11:733595
Phosphoproteome Profiling Revealed the Importance of mTOR Inhibition on CDK1 Activation to Further Regulate Cell Cycle Progression.
Jin L, Chen Y, Yan C, Guo X, Jiang T, Guli A, Song X, Wan Q, Shu Q, Ding S
Journal of proteome research 2021 May 7;20(5):2329-2339
Journal of proteome research 2021 May 7;20(5):2329-2339
ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer.
Gao X, Lu C, Chen C, Sun K, Liang Q, Shuai J, Wang X, Xu Y
OncoTargets and therapy 2020;13:6629-6643
OncoTargets and therapy 2020;13:6629-6643
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Mäkelä E, Löyttyniemi E, Salmenniemi U, Kauko O, Varila T, Kairisto V, Itälä-Remes M, Westermarck J
Cancers 2019 Nov 11;11(11)
Cancers 2019 Nov 11;11(11)
Increased ARPP-19 expression is associated with hepatocellular carcinoma.
Song H, Pan J, Liu Y, Wen H, Wang L, Cui J, Liu Y, Hu B, Yao Z, Ji G
International journal of molecular sciences 2014 Dec 24;16(1):178-92
International journal of molecular sciences 2014 Dec 24;16(1):178-92
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 11678-1-AP(ARPP-19 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-ARPP-19 (IP:11678-1-AP, 3ug; Detection:11678-1-AP 1:500) with mouse brain tissue lysate 5200ug.
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ARPP-19 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ARPP-19. This antibody recognizes human,mouse,rat antigen. The ARPP-19 antibody has been validated for the following applications: ELISA, IHC, WB, IP analysis.
